Open Nav

Please submit your session questions in advance at

Precision NanoSystems

  • James Taylor, Precision NanoSystems

Precision NanoSystems Inc. (“PNI”) provides comprehensive solutions for the development and manufacture of nanoparticle based precision medicines. This includes in the areas of gene therapy, gene editing and CRISPR, immunooncology, vaccines, rare disease and others. PNI’s core technology includes its NanoAssemblr microfluidic-based continuous flow platform for nanomedicine development and manufacture, and its GenVoy nanoparticle delivery technology for nucleic acid delivery. PNI provides its technology to leading pharmaceutical companies, biotechnology companies, and academic institutions in over 20 countries worldwide. Please find more information at

  • Date:Tuesday, February 12
  • Time:10:00 AM - 10:15 AM
  • Room:Chelsea
  • Location:7th Floor
  • Session Type:Company Presentation
  • Please submit your session questions in advance:

    Click here.

  • Company Presentation - Presentation Type:Privately Funded Company
  • Submission ID:23286
  • Goal for Presentation:Meet with potential partners and investors.
  • Company Website:
  • Company HQ City:Vancouver
  • Company HQ State:British Columbia
  • Company HQ Country:Canada
  • Total Amount Raised to Date, in All Rounds:$20,000,000
  • Size of Last Investment Round:$6,000,000
  • Previous and Current Investors:5AM Ventures, Telegraph Hill Partners, Rising Tide Fund
  • CEO/Top Company Official:James Taylor
  • Year Founded:2010
  • Main Therapeutic Focus:Tools/Drug Development Support Tech
  • Lead Product in Development:NanoAssemblr Platform for Nanomedicine Development
  • Development Phase of Primary Product:Other/Not Applicable
James Taylor
Precision NanoSystems